These findings highlight the superior efficacy of A20 CAR5 T cells in targeting and penetrating integrin αvβ6+/PD-L1+ tumor spheroids, suggesting their potential as a promising therapeutic approach for solid tumors (Figs. 5–6 and Fig. S3). The gene discussed is CD274; the disease is neoplasm.